Mahesh M
★    

India,
2014-12-11 14:45
(4215 d 01:47 ago)

Posting: # 14054
Views: 4,083
 

 MDIs formulation [Regulatives / Guidelines]

Dear All,

Can anyone suggest me what are the reasons for maintaining 30 sec gap between two inhalation (Puffs) in MDIs formulation? (Mentioned in SPC or PI)
And if we maintained the 30 sec gap between two puffs then chances miss to characterize the initial rate of absorption of the drug and the peak concentrations.

Regards
ElMaestro
★★★

Denmark,
2014-12-11 14:54
(4215 d 01:39 ago)

@ Mahesh M
Posting: # 14055
Views: 3,334
 

 MDIs formulation

Dear Mahesh M,

❝ Can anyone suggest me what are the reasons for maintaining 30 sec gap between two inhalation (Puffs) in MDIs formulation? (Mentioned in SPC or PI)


Inhaling consistently and correctly sounds like a trivial task but is in fact quite difficult. Especially when multiple inhalations are needed. A 30sec interval between any two inhalations adds some reassurance and is likely good for the efficacy. For the clinical staff it is a great help too that they don't need to rush every inhalation through. As you will see when you start the study 30secs is not a lot in practice.


❝ And if we maintained the 30 sec gap between two puffs then chances miss to characterize the initial rate of absorption of the drug and the peak concentrations.


Yes, if you are working on e.g. Formoterol or Salmeterol MDI then you'll find it difficult to capture the Cmax properly. You will sometimes see it on the first blood sample. There is no good way around it, for example you can't just ask the clinical to "work faster", so you'll have to live with it.

Pass or fail!
ElMaestro
Mahesh M
★    

India,
2014-12-12 07:57
(4214 d 08:35 ago)

@ ElMaestro
Posting: # 14059
Views: 3,310
 

 MDIs formulation

Hi ElMaestro,

Thanks for your responce.

❝ Especially when multiple inhalations are needed. A 30sec interval between any two inhalations adds some reassurance and is likely good for the efficacy.


do you have any reference for the same?


As you will see when you start the study 30secs is not a lot in practice.

We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)

please share your thoughts on that.

Regards
ElMaestro
★★★

Denmark,
2014-12-12 10:36
(4214 d 05:56 ago)

@ Mahesh M
Posting: # 14061
Views: 3,265
 

 MDIs formulation

Hi Mahesh M,

❝ do you have any reference for the same?


I don't.
I think it is a rather practical matter.

❝ We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)


Yes, you can e.g. write in your protocol that you are dosing approx. 30 secs apart and that t=0 is when the first puff is given.
By the way you don't always need to do everything strictly as per SPC for EU submissions. Other examples of SPC deviations in OIP studies include nose clips and total doses.

Good luck with your study.

Pass or fail!
ElMaestro
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
403 visitors (0 registered, 403 guests [including 26 identified bots]).
Forum time: 17:33 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5